Skip to content
★ Sign in to follow
Cleo Diagnostics Ltd logo

Cleo Diagnostics Ltd Stock: price and insider trades · Australia

ISIN AU0000288045AU·Mcap A$44.1M

1 insider bought €276k of shares over the last 90 days, the latest by Unknown, filed 24 Aug 2026.

Cleo Diagnostics Ltd: what insiders have been doing

Cleo Diagnostics Ltd is a listed company. Its insiders report their share dealings to ASX. Over the twelve months to 8 November 2026, 3 filings were filed, from 2 insiders.

The flow runs one way only: 2 insiders bought (3 purchases totalling €276k) and nobody sold on the market. The totals exclude 2 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The buyers include 2 senior executives. Lucinda Joan Frawley filed the largest purchase, €276k, on 24 August 2026.

The clock since the last published purchase (24 August 2026) now reads 76 days. Most trades are made public on the day they happen. This delay matters because a trade only becomes useful information once it is public.

With 3 filings in twelve months, the company is in line with the median of 3 filings across the 2,535 companies we follow on the same exchange. Over the whole record (from 2026), the tally stands at 3 purchases and no sales.

Source: insider filings from ASX. Past trades are no guide to future returns.

Insider Decl.
3
Thresholds
n/a
Buy Volume
€276,120
3 ops. · all time
Sell Volume
n/a
n/a

Who traded when

BuySale
Unknown3 buys

Since the insiders bought

  • Unknown
    Filed 24 Aug 2026 · 76 days ago · €276k
    -18.1%
    Entry A$0.36 · Close at T+30 A$0.29

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Financial data

as of FY 2026

FY ended June 2026 · cache

A$0.31
Analyst consensus
·
Income statement
EBITDA-A$7.8M
Net income-A$5.9M0.0% margin
Valuation
P/Book8.4x
Beta0.52
Balance sheet & cash
Market capA$44.1M
Total debtA$1.6M
Free Cash Flow-A$4.9M
Profitability & ownership
ROE-109.5%
ROA-52.1%
% insiders38.5%
% institutions0.0%
Last declaration on 24 August 2026
Declarations3 total
  • ▲
    Executives
    Executives(filed)
    450,000 AUD0ASX
  • ▲
    Executives
    Executives(filed)
    0ASX
  • ▲
    Executives
    Executives(filed)
    0ASX

3 of 3 declarations

About Cleo Diagnostics Ltd

Cleo Diagnostics Ltd is a company listed on the XASX, specializing in the development of medical diagnostic solutions. It focuses on innovation in diagnostic testing to enhance healthcare.